Jan 7 (Reuters) - Sequana Medical NV SEQUA.BR :
* SEQUANA MEDICAL ANNOUNCES FIRST PATIENT ENROLLED IN RED
DESERT –
REPEATED DOSE ALFAPUMP® DSR STUDY FOR TREATMENT OF
DIURETIC-RESISTANT HEART FAILURE PATIENTS
* STUDY AIMS TO EVALUATE SAFETY OF ALFAPUMP DSR IN PATIENTS
WITH
HEART FAILURE
* WE LOOK FORWARD TO REPORTING INITIAL INTERIM RESULTS IN Q2
2020
AND PRESENTING FINAL RESULTS IN Q3 2020
Source text for Eikon: ID:nGNXbBBZK2
Further company coverage: SEQUA.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))